12-22065215-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_018686.6(CMAS):​c.1209C>T​(p.Tyr403Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00367 in 1,614,060 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 17 hom. )

Consequence

CMAS
NM_018686.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.426

Publications

7 publications found
Variant links:
Genes affected
CMAS (HGNC:18290): (cytidine monophosphate N-acetylneuraminic acid synthetase) This gene encodes an enzyme that converts N-acetylneuraminic acid (NeuNAc) to cytidine 5'-monophosphate N-acetylneuraminic acid (CMP-NeuNAc). This process is important in the formation of sialylated glycoprotein and glycolipids. This modification plays a role in cell-cell communications and immune responses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
ST8SIA1 (HGNC:10869): (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1) Gangliosides are membrane-bound glycosphingolipids containing sialic acid. Ganglioside GD3 is known to be important for cell adhesion and growth of cultured malignant cells. The protein encoded by this gene is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to GM3 to produce gangliosides GD3 and GT3. The encoded protein may be found in the Golgi apparatus and is a member of glycosyltransferase family 29. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 12-22065215-C-T is Benign according to our data. Variant chr12-22065215-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 790461.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.426 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CMASNM_018686.6 linkc.1209C>T p.Tyr403Tyr synonymous_variant Exon 8 of 8 ENST00000229329.7 NP_061156.1 Q8NFW8-1
CMASNR_135117.2 linkn.1123C>T non_coding_transcript_exon_variant Exon 7 of 7
LOC105369690XR_931423.4 linkn.445+1130G>A intron_variant Intron 4 of 4
LOC105369690XR_931424.4 linkn.1459+1130G>A intron_variant Intron 4 of 4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CMASENST00000229329.7 linkc.1209C>T p.Tyr403Tyr synonymous_variant Exon 8 of 8 1 NM_018686.6 ENSP00000229329.2 Q8NFW8-1
CMASENST00000534981.5 linkn.*245C>T non_coding_transcript_exon_variant Exon 7 of 7 1 ENSP00000446239.1 Q8NFW8-2
CMASENST00000534981.5 linkn.*245C>T 3_prime_UTR_variant Exon 7 of 7 1 ENSP00000446239.1 Q8NFW8-2
ST8SIA1ENST00000536535.1 linkn.291+1130G>A intron_variant Intron 3 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.00283
AC:
430
AN:
152150
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.0115
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00437
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00344
AC:
866
AN:
251420
AF XY:
0.00369
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00275
Gnomad ASJ exome
AF:
0.0122
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00504
Gnomad OTH exome
AF:
0.00701
GnomAD4 exome
AF:
0.00376
AC:
5493
AN:
1461792
Hom.:
17
Cov.:
30
AF XY:
0.00379
AC XY:
2757
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33480
American (AMR)
AF:
0.00271
AC:
121
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0117
AC:
305
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.000707
AC:
61
AN:
86254
European-Finnish (FIN)
AF:
0.000842
AC:
45
AN:
53418
Middle Eastern (MID)
AF:
0.00381
AC:
22
AN:
5768
European-Non Finnish (NFE)
AF:
0.00419
AC:
4660
AN:
1111934
Other (OTH)
AF:
0.00440
AC:
266
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
276
552
829
1105
1381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00282
AC:
429
AN:
152268
Hom.:
2
Cov.:
32
AF XY:
0.00258
AC XY:
192
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.000722
AC:
30
AN:
41552
American (AMR)
AF:
0.00203
AC:
31
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
40
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4816
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10608
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00435
AC:
296
AN:
68028
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00424
Hom.:
10
Bravo
AF:
0.00298
EpiCase
AF:
0.00573
EpiControl
AF:
0.00693

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CMAS: BP4, BP7, BS2 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
1.9
DANN
Benign
0.81
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146887115; hg19: chr12-22218149; COSMIC: COSV99982598; COSMIC: COSV99982598; API